BACKGROUND: X-linked blue cone monochromatism (BCM) has to be differentiated from x-linked cone dystrophy and autosomal recessive rod monochromatism. METHODS: In nine male patients with congenital cone dysfunction (one family, six single cases; age range: 9-55 years), mutations in the red/green opsin gene cluster were confirmed. Clinical findings were analyzed retrospectively. RESULTS: In one family and three single cases, a single red-green hybrid gene was found carrying a Cys203Arg mutation. Two patients had multiple opsin genes, a red/green hybrid gene and at least one green pigment gene, all carrying the Cys203Arg mutation. In one patient, a large deletion of the locus control region and parts of the red pigment gene were detected. Two patients (ages: 45 and 55 years) complained about progression. Two patients presented with nystagmus. Refractive errors (+8.0 and -11.0 D) and visual acuity were variable (0.05-0.3). Only four patients had a visual acuity > or = 0.1. In two patients, visual acuity could be improved using blue filter glasses. Four of five patients > or = 25 years had dystrophic alterations in the macula. Severe color vision defects and relative central scotoma were present in all patients. In the electroretinogram, residual cone responses were detected in 2/8 patients. CONCLUSIONS: Hybrid red/green opsin genes carrying the Cys203Arg mutation are a frequent cause of BCM in German patients. Molecular genetic evaluation is mandatory for adequate diagnosis of patients since from the clinical data only two patients were diagnosed as having BCM. In the other patients, either rod monochromatism or cone-rod dystrophy could not be excluded with certainty. The patients should be cautioned that macular dystrophy may develop in adults older than 30 years.
BACKGROUND:X-linked blue cone monochromatism (BCM) has to be differentiated from x-linked cone dystrophy and autosomal recessive rod monochromatism. METHODS: In nine male patients with congenital cone dysfunction (one family, six single cases; age range: 9-55 years), mutations in the red/green opsin gene cluster were confirmed. Clinical findings were analyzed retrospectively. RESULTS: In one family and three single cases, a single red-green hybrid gene was found carrying a Cys203Arg mutation. Two patients had multiple opsin genes, a red/green hybrid gene and at least one green pigment gene, all carrying the Cys203Arg mutation. In one patient, a large deletion of the locus control region and parts of the red pigment gene were detected. Two patients (ages: 45 and 55 years) complained about progression. Two patients presented with nystagmus. Refractive errors (+8.0 and -11.0 D) and visual acuity were variable (0.05-0.3). Only four patients had a visual acuity > or = 0.1. In two patients, visual acuity could be improved using blue filter glasses. Four of five patients > or = 25 years had dystrophic alterations in the macula. Severe color vision defects and relative central scotoma were present in all patients. In the electroretinogram, residual cone responses were detected in 2/8 patients. CONCLUSIONS: Hybrid red/green opsin genes carrying the Cys203Arg mutation are a frequent cause of BCM in German patients. Molecular genetic evaluation is mandatory for adequate diagnosis of patients since from the clinical data only two patients were diagnosed as having BCM. In the other patients, either rod monochromatism or cone-rod dystrophy could not be excluded with certainty. The patients should be cautioned that macular dystrophy may develop in adults older than 30 years.
Authors: E Reyniers; M N Van Thienen; F Meire; K De Boulle; K Devries; P Kestelijn; P J Willems Journal: Genomics Date: 1995-09-20 Impact factor: 5.736
Authors: S Kohl; B Baumann; M Broghammer; H Jägle; P Sieving; U Kellner; R Spegal; M Anastasi; E Zrenner; L T Sharpe; B Wissinger Journal: Hum Mol Genet Date: 2000-09-01 Impact factor: 6.150
Authors: B Wissinger; D Gamer; H Jägle; R Giorda; T Marx; S Mayer; S Tippmann; M Broghammer; B Jurklies; T Rosenberg; S G Jacobson; E C Sener; S Tatlipinar; C B Hoyng; C Castellan; P Bitoun; S Andreasson; G Rudolph; U Kellner; B Lorenz; G Wolff; C Verellen-Dumoulin; M Schwartz; F P Cremers; E Apfelstedt-Sylla; E Zrenner; R Salati; L T Sharpe; S Kohl Journal: Am J Hum Genet Date: 2001-08-30 Impact factor: 11.025
Authors: Joseph Carroll; Alfredo Dubra; Jessica C Gardner; Liliana Mizrahi-Meissonnier; Robert F Cooper; Adam M Dubis; Rick Nordgren; Mohamed Genead; Thomas B Connor; Kimberly E Stepien; Dror Sharon; David M Hunt; Eyal Banin; Alison J Hardcastle; Anthony T Moore; David R Williams; Gerald Fishman; Jay Neitz; Maureen Neitz; Michel Michaelides Journal: Invest Ophthalmol Vis Sci Date: 2012-12-05 Impact factor: 4.799
Authors: Hendrik P N Scholl; Jan Kremers; Dorothea Besch; Eberhart Zrenner; Herbert Jägle Journal: Graefes Arch Clin Exp Ophthalmol Date: 2005-08-05 Impact factor: 3.117
Authors: Jessica C Gardner; Tom R Webb; Naheed Kanuga; Anthony G Robson; Graham E Holder; Andrew Stockman; Caterina Ripamonti; Neil D Ebenezer; Olufunmilola Ogun; Sophie Devery; Genevieve A Wright; Eamonn R Maher; Michael E Cheetham; Anthony T Moore; Michel Michaelides; Alison J Hardcastle Journal: Am J Hum Genet Date: 2010-06-24 Impact factor: 11.025
Authors: Anne Moskowitz; Ronald M Hansen; James D Akula; Susan E Eklund; Anne B Fulton Journal: Invest Ophthalmol Vis Sci Date: 2008-09-29 Impact factor: 4.799
Authors: Artur V Cideciyan; Robert B Hufnagel; Joseph Carroll; Alexander Sumaroka; Xunda Luo; Sharon B Schwartz; Alfredo Dubra; Megan Land; Michel Michaelides; Jessica C Gardner; Alison J Hardcastle; Anthony T Moore; Robert A Sisk; Zubair M Ahmed; Susanne Kohl; Bernd Wissinger; Samuel G Jacobson Journal: Hum Gene Ther Date: 2013-10-30 Impact factor: 5.695